The Best Summer TV Series Is ABC’s “Boston Med”

July 28th, 2010

Forget about Grey’s Anatomy and ER when you can go inside a real hospital.
does anyone know when this will take effect

HCA’s $4.6 Billion IPO: Three Storylines To Follow

July 28th, 2010

The HCA IPO could make hospitals a hot investing category. What did its private equity owners do to earn their pay?
like our content consider our rss feed!

Genzyme’s Hidden Value

July 28th, 2010

The timing of Genzyme’s earnings growth is as important as the company’s overall sales when it comes to M&A.
thanks for delivering this story to me

Defending Fish Oil, Criticizing Glaxo

July 28th, 2010

Steven Salzberg wrote earlier this week about GlaxoSmithKline’s marketing of fish oil, a supplement, as a drug in the form of its omega-3 fatty acid pill, Lovaza. I took issue with his post, because I think the data for the fish oil omega-3s, DHA and EPA, are pretty strong. (I’ve previously written about this here [...]
does anyone know the real story

The Sad Truth About $100,000 Cancer Drugs

July 28th, 2010

An important New Yorker story focuses on the unfortunate reality of rare, expensive treatments: they fail most of the time.
how doe this impact my state

Dendreon Gets Some Respect

July 28th, 2010

Pivotal Provenge results are published in the New England Journal of Medicine.
thanks for visiting today!

Sanofi-Aventis Setback Could Mean Generic Biotech Drugs Are On The Way

July 26th, 2010

In a move with big implications for the biotech industry, the FDA has approved a generic version of Sanofi-Aventis’ injected blood thinner Lovenox.
thanks for visiting today!

Novartis Exec: Golden Age Of Generic Biotech Drugs Is Coming

July 26th, 2010

The FDA’s  surprise approval of Novartis’ generic version of the blood thinner Lovenox after a four-year review is a signal the FDA may be more willing to approve complex generic products in the coming years, says Jeffrey George, global head of Novartis’s Sandoz generic drug unit.
“It underscores that the FDA really does have the institutional [...]
company cost health insurance low orlando

Onyx’s Next Blockbuster?

July 26th, 2010

Onyx says its multiple myeloma drug carfilzomib performed well in a clinical trial.
check out our ads below, they maybe of interest.

Fish Oil Salesmen

July 26th, 2010

Lovaza is the only fish oil supplement with FDA approval. A new marketing campaign makes it sound special – but is it?
it should be interested what change will this make